BioCentury | Nov 14, 2019
Tools & Techniques

Weizmann 10K Project aims for -omics sweet spot

...was published in a 2015 Cell study and spun out into DayTwo Ltd. the same year. DayTwo...
BioCentury | Aug 2, 2019
Distillery Therapeutics

Gut microbe to reduce ALS severity

...DISEASE CATEGORY: Neurology INDICATION: Amyotrophic lateral sclerosis (ALS) Co-founders and collaborators of DayTwo Ltd. and BiomX Ltd...
BioCentury | Aug 1, 2019
Translation in Brief

Making connections between ALS and gut microbes

...Eran Elinav, who co-led the study, are Weizmann professors and co-founders of microbiome-based nutrition company DayTwo Ltd....
BioCentury | Jul 26, 2019
Preclinical News

July 26 preclinical Quick Takes: Ribon's new mechanism for PARP inhibitors, a microbiome-ALS link and more

...$65 Million Series B to Target monoPARPs" ). Linking the gut microbiome with ALS symptoms DayTwo Ltd....
...polymerase; TYK2 - tyrosine kinase 2 Hongjiang Li and Sandi Wong, Staff Writers BMS-986165 BiomX Ltd. Bristol-Myers Squibb Co. Cytokinetics Inc. DayTwo Ltd. NanoString...
BioCentury | Mar 5, 2019
Financial News

First close for Seventure's new microbiome fund

...Science Inc. (Tokyo, Japan); Neurimm Therapeutics (Paris, France), Siolta Therapeutics Inc. (San Francisco, Calif.); and DayTwo Ltd....
BioCentury | Sep 10, 2018
Preclinical News

Cell papers may help predict gut colonization by bacterial treatments

...immunology at Weizmann and a founder of microbiome companies BiomX Ltd. (Ness Ziona, Israel) and DayTwo Ltd....
...to aid a colony in engrafting to the gut (see "Bugs On Film" ). Mark Zipkin BiomX Ltd. DayTwo Ltd. Weizmann...
BioCentury | Feb 28, 2018
Preclinical News

The microbiome can predict disease risk

...examination of the microbiome's contribution. Segal and co-lead author Eran Elinav are scientific founders of DayTwo Ltd....
BioCentury | Feb 3, 2017
Company News

Weizmann Institute of Science, DayTwo, J&J deal

...The Janssen Human Microbiome Institute (JHMI) of Johnson & Johnson partnered with DayTwo and the Weizmann...
...N.J. DayTwo Ltd. , Tel Aviv, Israel Weizmann Institute of Science , Rehovot, Israel Business: Endocrine/Metabolic Alicia Parker DayTwo Ltd. Johnson...
BioCentury | Feb 2, 2017
Company News

Caelus investment among J&J's microbiome deals

...The pharma also announced a deal to develop a microbiome-based nutritional recommendation platform with DayTwo Ltd....
...diabetes and metabolic syndrome-associated disorders. The platform is based on research by Weizmann scientists and DayTwo...
...declined to provide additional terms of the deals. Jaime De Leon Caelus Health Johnson & Johnson Weizmann Institute of Science CP-001 DayTwo Ltd. DIA Disease...
Items per page:
1 - 9 of 9
BioCentury | Nov 14, 2019
Tools & Techniques

Weizmann 10K Project aims for -omics sweet spot

...was published in a 2015 Cell study and spun out into DayTwo Ltd. the same year. DayTwo...
BioCentury | Aug 2, 2019
Distillery Therapeutics

Gut microbe to reduce ALS severity

...DISEASE CATEGORY: Neurology INDICATION: Amyotrophic lateral sclerosis (ALS) Co-founders and collaborators of DayTwo Ltd. and BiomX Ltd...
BioCentury | Aug 1, 2019
Translation in Brief

Making connections between ALS and gut microbes

...Eran Elinav, who co-led the study, are Weizmann professors and co-founders of microbiome-based nutrition company DayTwo Ltd....
BioCentury | Jul 26, 2019
Preclinical News

July 26 preclinical Quick Takes: Ribon's new mechanism for PARP inhibitors, a microbiome-ALS link and more

...$65 Million Series B to Target monoPARPs" ). Linking the gut microbiome with ALS symptoms DayTwo Ltd....
...polymerase; TYK2 - tyrosine kinase 2 Hongjiang Li and Sandi Wong, Staff Writers BMS-986165 BiomX Ltd. Bristol-Myers Squibb Co. Cytokinetics Inc. DayTwo Ltd. NanoString...
BioCentury | Mar 5, 2019
Financial News

First close for Seventure's new microbiome fund

...Science Inc. (Tokyo, Japan); Neurimm Therapeutics (Paris, France), Siolta Therapeutics Inc. (San Francisco, Calif.); and DayTwo Ltd....
BioCentury | Sep 10, 2018
Preclinical News

Cell papers may help predict gut colonization by bacterial treatments

...immunology at Weizmann and a founder of microbiome companies BiomX Ltd. (Ness Ziona, Israel) and DayTwo Ltd....
...to aid a colony in engrafting to the gut (see "Bugs On Film" ). Mark Zipkin BiomX Ltd. DayTwo Ltd. Weizmann...
BioCentury | Feb 28, 2018
Preclinical News

The microbiome can predict disease risk

...examination of the microbiome's contribution. Segal and co-lead author Eran Elinav are scientific founders of DayTwo Ltd....
BioCentury | Feb 3, 2017
Company News

Weizmann Institute of Science, DayTwo, J&J deal

...The Janssen Human Microbiome Institute (JHMI) of Johnson & Johnson partnered with DayTwo and the Weizmann...
...N.J. DayTwo Ltd. , Tel Aviv, Israel Weizmann Institute of Science , Rehovot, Israel Business: Endocrine/Metabolic Alicia Parker DayTwo Ltd. Johnson...
BioCentury | Feb 2, 2017
Company News

Caelus investment among J&J's microbiome deals

...The pharma also announced a deal to develop a microbiome-based nutritional recommendation platform with DayTwo Ltd....
...diabetes and metabolic syndrome-associated disorders. The platform is based on research by Weizmann scientists and DayTwo...
...declined to provide additional terms of the deals. Jaime De Leon Caelus Health Johnson & Johnson Weizmann Institute of Science CP-001 DayTwo Ltd. DIA Disease...
Items per page:
1 - 9 of 9